These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8903281)

  • 1. Safety of calcium antagonists: dissecting the evidence.
    Messerli FH
    Am J Cardiol; 1996 Nov; 78(9A):19-23. PubMed ID: 8903281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel antagonists: morbidity and mortality--what's the evidence?
    Straka RJ; Swanson AL; Parra D
    Am Fam Physician; 1998 Apr; 57(7):1551-60. PubMed ID: 9556644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do calcium antagonists cause death, gastrointestinal bleeding, and cancer?
    Kaplan NM
    Am J Cardiol; 1996 Oct; 78(8):932-3. PubMed ID: 8888668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist.
    Davis WB; Wells SR; Kuller JA; Thorp JM
    Obstet Gynecol Surv; 1997 Mar; 52(3):198-201. PubMed ID: 9061722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1995: the year of the calcium antagonist controversy.
    Cohen JD
    Curr Opin Nephrol Hypertens; 1996 May; 5(3):214-8. PubMed ID: 8737855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
    Kanamasa K; Kimura A; Miyataka M; Takenaka T; Ishikawa K
    Cancer; 1999 Mar; 85(6):1369-74. PubMed ID: 10189144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of calcium antagonists: more ACTION.
    Messerli FH; Staessen JA
    Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803
    [No Abstract]   [Full Text] [Related]  

  • 12. Controversies concerning calcium antagonists.
    Lichtlen PR
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):409-12. PubMed ID: 8924053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
    Furberg CD; Psaty BM; Meyer JV
    Circulation; 1995 Sep; 92(5):1326-31. PubMed ID: 7648682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists: a scandal in need of an inquiry.
    Jackson G
    Int J Clin Pract; 2003; 57(6):455. PubMed ID: 12918880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Calcium antagonists: safe or unsafe?].
    Rosendaal FR; Psaty BM; Furberg CD
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):916-8. PubMed ID: 8676969
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of barnidipine hydrochloride on the autonomic nervous system: difference between short- and long-acting components of calcium antagonist].
    Soejima K; Akaishi M; Oyamada K; Mitamura H; Ogawa S
    J Cardiol; 1997 Jul; 30(1):13-8. PubMed ID: 9253691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?].
    Martsevich SIu
    Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers in the dock: innocent or guilty?
    Mackay JA; Sever PS
    J Hum Hypertens; 1996 May; 10(5):277-80. PubMed ID: 8817399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists: when the content does not justify the headline.
    Jackson G
    Br J Clin Pract; 1995; 49(6):283-4. PubMed ID: 8554947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.